Raloxifene and Antiestrogenic Gonadorelin Inhibits Intestinal Tumorigenesis by Modulating Immune Cells and Decreasing Stem-Like Cells
Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-13-0345
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2014
Authors
Publisher
American Association for Cancer Research (AACR)